Streetbeat News

Earnings

ACM

AECOM (NYSE:ACM) reported a 12% Y/Y revenue increase in Q4 FY23 to $3.84 billion, surpassing estimates. Adjusted EPS of $1.01 beat consensus, and the company raised its share buyback authorization to $1 billion and increased its quarterly dividend by 22%. AECOM's FY24 outlook anticipates adjusted EPS of $4.35-$4.55 and adjusted EBITDA of $1.065-$1.105 billion. Shares rose 1.65% in premarket trading.

Portfolio Pulse from Lekha Gupta

November 14, 2023 | 12:54 pm

ATOS

Atossa Therapeutics (NASDAQ:ATOS) reported a Q3 EPS loss of $(0.05), surpassing the consensus estimate of $(0.07) by 28.57%. This represents a 16.67% improvement from the $(0.06) per share loss reported in the same quarter of the previous year.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 12:53 pm

MGIC

Magic Software forecasts Q4 revenue to be between $115M-$125M, which falls short of the estimated $133.65M.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 12:53 pm

MGIC

Magic Software (NASDAQ:MGIC) reported Q3 adjusted EPS of $0.21, missing the $0.27 estimate, and sales of $129.48M, below the $146.40M estimate. This reflects a 25% decrease in earnings and a 10.06% decrease in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 12:49 pm

EBIX

Ebix, Inc. (NASDAQ:EBIX) reported a Q3 adjusted EPS of $(0.11), significantly missing the analyst consensus estimate of $0.07. This represents a sharp decline from the $0.70 per share earned in the same quarter of the previous year. Quarterly sales were also below expectations at $119.23M, missing the $124.28M estimate and showing a 53.77% decrease from the previous year's same quarter sales of $257.90M.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 12:46 pm

NETI

Eneti Inc. (NYSE:NETI) reported Q3 earnings with an EPS of $0.49, surpassing the estimate of $0.27 by 81.48%. However, revenue decreased by $16.00 million compared to the same period last year. In the previous quarter, Eneti's EPS beat estimates by $0.02, leading to a 1.75% share price increase the following day.

Portfolio Pulse from Benzinga Insights

November 14, 2023 | 12:45 pm

INVO

INVO Bioscience, Inc. (NASDAQ:INVO) shares increased by over 31% in pre-market trading due to a narrower Q3 loss and a 314% surge in quarterly sales. Other stocks experienced pre-market movements, with notable gainers including TCRT, AIRE, HRYU, THRX, RDHL, ABSI, PXMD, ADN, OMIC, and losers such as SKIN, HROW, AUVI, AKLI, HTCR, PRSO, FSR, TCON, TENX, XAIR.

Portfolio Pulse from Lisa Levin

November 14, 2023 | 12:41 pm

BCLI

Brainstorm Cell (NASDAQ:BCLI) reported a Q3 EPS loss of $(0.03), significantly beating the $(0.14) loss per share estimated by analysts. This represents an 84.21% improvement from the $(0.19) loss per share reported in the same quarter of the previous year.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 12:41 pm

NPWR

NET Power (NYSE:NPWR) reported a Q3 loss of $(0.44) per share, significantly missing the analyst consensus estimate of $(0.05) by 780 percent.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 12:40 pm

CLBT

Cellebrite DI (NASDAQ:CLBT) reported Q3 earnings with an EPS of $0.09, surpassing the estimate of $0.05 by 80%. Revenue increased by $12.50 million compared to the same period last year. Despite beating EPS estimates last quarter, CLBT's share price dropped by 0.5% the following day.

Portfolio Pulse from Benzinga Insights

November 14, 2023 | 12:40 pm